Dr. Maria Cristina Betancourt Quiles, MD

Media Releases

Get to know Pulmonologist Dr. Maria Cristina Betancourt Quiles, who serves patients in San Juan, Puerto Rico.

An established pulmonologist, Dr. Betancourt Quiles is affiliated with San Juan City Hospital in Puerto Rico.

Throughout her academic career, she graduated with her medical degree from Universidad Central del Caribe School of Medicine in 2003. She went on to complete her residency in internal medicine and her fellowship in pulmonary diseases at San Juan City Hospital in 2006 and 2011, respectively.

As a testament of her continued education, the doctor is board-certified in pulmonary disease and internal medicine by the American Board of Internal Medicine (ABIM). The ABIM is a physician-led, non-profit, independent evaluation organization driven by doctors who want to achieve higher standards for better care in a rapidly changing world.

Pulmonology is a medical specialty that deals with diseases involving the respiratory tract. A pulmonologist is an internal medicine physician who specializes in preventing, diagnosing, and treating conditions and diseases that affect the lungs, bronchial tubes, and the respiratory system, including the nose, pharynx, and throat.

Recommended Articles

• What is Acute Bronchitis?

  What is Bronchitis?We often run under weather catching a flu or a cold that stays on for a couple of days to weeks, after which we normally get back to normal. However, sometimes even a small infection of cold or flu, could turn into a bronchitis infection causing much disturbance to your normal...

• Pneumonia: The Signs and Symptoms

  You may be a patient concerned about the symptoms of pneumonia or you may have a friend or relative with symptoms suggestive of pneumonia. There are no universal symptoms that apply to every individual. The symptoms will vary from person to person and depend on the specific situation of each and...

• New Cystic Fibrosis Treatment Shows Promise for those with a Specific Gene Mutation

  The data released on July 18th from three clinical trials conducted by Vertex Pharmaceuticals revealed promising results. The drugs that were tested in these trials are three different triple combination regimes that are designed to treat the underlying cause of cystic fibrosis in patients with the...

• A Cystic Fibrosis App to Bring Data to Market

  For many people with CF, remembering their daily treatment regimens and medication schedules can seem daunting and difficult. Most patients acclaim that if they had a resource, such as an app, that would make their health management easier to handle, that they would love to try it. In addition to...

• New Study: ADHD's Potential Impact on Cystic Fibrosis

  Results from a recent study have shown that 15% of Adults with Cystic Fibrosis (CF) had definitive symptoms for Attention Deficit Hyperactivity Disorder (ADHD).While past research had shown a prevalence of anxiety and depression in adults with CF, the incidence of ADHD was described as...

• Pleurisy vs. Bronchitis: Differences and Similarities

  What is pleurisy?Pleurisy is a condition, in which the lining that surrounds the lungs and the interior of the chest cavity is inflamed. Due to the inflammation of the pleura, this condition is also called as pleuritis. The pleural space is the space between the lungs and the chest cavity wall....